Aggressive Goals Fuel Research, Growth at 'The James'
May 20th 2010The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened on July 9, 1990,as the adult patient-care component of The Ohio State University (OSU) Comprehensive Cancer Center (CCC).Today, "The James," as it is referred to, is the only dedicated cancer hospital in the Midwest.
Read More
Genomic Research Fuels Innovation at Johns Hopkins
May 19th 2010The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of only 40 cancer centers in the country designated by the National Cancer Institute as a Comprehensive Center. The physician researchers at the institution have been characterizing the acquired genome defects in cancers for the better part of the past few decades.
Read More
Pipeline and Collaborations Could Propel Seattle Genetics
May 19th 2010If there is such a thing as a business trifecta, Seattle Genetics is nearly there. The Washington state biotechnology company is focused on the development and commercialization of monoclonal antibody–based therapies for the treatment of cancer and autoimmune disease. And with a potent pipeline of potential products and numerous technology and marketing collaborations in place, the opportunities for growth are in the air.
Read More
Will 2010 Be the Year that Ariad Closes the Gap?
May 19th 2010When companies talk about "narrowing the gap," they typically mean closing the distance that separates them from their leading competitor. At Ariad Pharmaceuticals, however, that expression has taken on a new meaning: narrowing the distance from development to market for its two most promising compounds.
Read More
Tulane Cancer Center's Multifocal Mission: Teaching, Research, and Patient Care
May 18th 2010In post-Katrina New Orleans, Louisiana, people refer to their return home and the revival of the city as �being back.� Today, the human spirit is thriving in the Big Easy�s resurrected communities and New Orleans is growing. The Tulane Cancer Center (TCC) at Tulane University Medical School has been the beneficiary of some of that growth.
Read More
Clarient Launches Pulmotype to Help Oncologists Choose the Right Therapy
May 18th 2010In early February, Clarient Inc announced the commercial launch of its Insight Dx Pulmotype test that helps pathologists classify specific types of lung cancer so physicians can prescribe the most effective therapies.
Read More